Please try another search
For the three months ended 31 March 2022, Bio-FD&C Co Ltd revenues increased 95% to W4.36B. Net income decreased 84% to W72.7M. Revenues reflect South Korea (Country) segment increase from W1.63B to W3.77B, Other segment increase from W33.5M to W140.2M. Net income was offset by Stock-based Com increase from W149K to W796.4M (expense), Salaries & Wages increase of 52% to W810.6M (expense).
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 4740.58 | 3927.6 | 3591.38 | 3332.53 |
Gross Profit | 3084.33 | 2905.82 | 2553.42 | 2485.74 |
Operating Income | 1558.09 | 1306.6 | 1313.88 | 855.44 |
Net Income | 2350.71 | 1142.44 | 1234.37 | 857.63 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 62812.54 | 61306.83 | 60266.48 | 59744.2 |
Total Liabilities | 4195.61 | 5054.32 | 5160.96 | 5895.77 |
Total Equity | 58616.93 | 56252.51 | 55105.52 | 53848.43 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 2312.89 | 1336.94 | 1758.55 | 638.4 |
Cash From Investing Activities | 1329.46 | -1341.42 | -10859.47 | 7565.84 |
Cash From Financing Activities | -1006.74 | -6.49 | -1206.13 | -6.01 |
Net Change in Cash | 2565.34 | 1.4 | -10322.32 | 8227.97 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review